4
Changes in Ownership
PROTHENA CORP PUBLIC LTD CO Filed Acc 0001140361-23-029929
Chief Medical Officer sold 4,669 shares at an average $74.22 ($346,516)
- Chief Medical Officer acquired 4,669 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Garren Hideki Chief Medical Officer | 2023-06-14 | Option exercise 10b5-1 | +4,669 | $24.90 | $116,258 | 4,669 | D: show line 1 in the form |
| Garren Hideki Chief Medical Officer | 2023-06-14 | Sale 10b5-1 | −509 | $72.45 | $36,879 | 4,160 | D: show line 2 in the form |
| Garren Hideki Chief Medical Officer | 2023-06-14 | Sale 10b5-1 | −971 | $73.31 | $71,184 | 3,189 | D: show line 3 in the form |
| Garren Hideki Chief Medical Officer | 2023-06-14 | Sale 10b5-1 | −2,534 | $74.59 | $189,010 | 655 | D: show line 4 in the form |
| Garren Hideki Chief Medical Officer | 2023-06-14 | Sale 10b5-1 | −655 | $75.49 | $49,443 | 0 | D: show line 5 in the form |
| Open-market sales · 4,669 sh · avg $74.22 · $346,516 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Garren Hideki Chief Medical Officer | 2023-06-14 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,669 | 205,331 | D: show line 6 in the form |
Loading xslF345X04/form4.xml…